3-Methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid
97%
- Product Code: 73067
CAS:
113942-30-6
Molecular Weight: | 195.14 g./mol | Molecular Formula: | C₆H₅N₅O₃ |
---|---|---|---|
EC Number: | MDL Number: | MFCD12032160 | |
Melting Point: | 166-168°C | Boiling Point: | |
Density: | Storage Condition: | 2-8°C |
Product Description:
This compound is primarily utilized in the development of pharmaceutical agents, particularly in the synthesis of anticancer drugs. Its structure is key in creating prodrugs that release active alkylating agents, which target and damage DNA in cancer cells, leading to cell death. It is often incorporated into formulations designed for targeted therapy, enhancing the efficacy and reducing the side effects of chemotherapy. Additionally, its derivatives are explored for their potential in treating various types of tumors, making it a valuable component in oncological research and drug development.
Product Specification:
Test | Specification |
---|---|
APPEARANCE | White - Slightly pale yellow Crystal - Powder Solid |
PURITY | 96.5 100% |
PROTON NMR SPECTRUM | Conforms to Structure |
MELTING POINT | 161 165? |
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.025 | 10-20 days | ฿1,320.00 |
+
-
|
0.100 | 10-20 days | ฿2,250.00 |
+
-
|
0.500 | 10-20 days | ฿6,960.00 |
+
-
|
1.000 | 10-20 days | ฿11,440.00 |
+
-
|
3-Methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxylic acid
This compound is primarily utilized in the development of pharmaceutical agents, particularly in the synthesis of anticancer drugs. Its structure is key in creating prodrugs that release active alkylating agents, which target and damage DNA in cancer cells, leading to cell death. It is often incorporated into formulations designed for targeted therapy, enhancing the efficacy and reducing the side effects of chemotherapy. Additionally, its derivatives are explored for their potential in treating various types of tumors, making it a valuable component in oncological research and drug development.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :